Atrovent
Product Images NDC 53002-8410

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atrovent (NDC 53002-8410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrovent 01

Chemical structure diagram showing the molecular formula of the active ingredient in Atrovent HFA, including its complex bicyclic and aromatic components along with bromide and water components indicated as Br·H2O.*

FDA Label Image

Atrovent 02

Two line graphs titled Day 1 and Day 85 show changes in FEV1 (liters) over 8 hours after drug administration for Atrovent HFA with different doses (42 mcg and 84 mcg), placebo, and Atrovent CFC 42 mcg. The graphs compare lung function over time following drug use.*

FDA Label Image

Atrovent 03

An instructional diagram illustrating the components of the Atrovent HFA inhaler, showing the canister, mouthpiece, dose indicator, and dustcap arranged in exploded view for assembly or identification.*

FDA Label Image

Atrovent 04

A line chart showing time-dependent changes with data series for various day intervals labeled 0, 20, 40, 60, 80, 100, 120, 140, 160, 180, and 200. The x-axis represents an unlabeled metric, and the y-axis represents values decreasing from 200 to 0. The chart tracks multiple groups over the time scale.*

FDA Label Image

Atrovent 05

An instructional illustration showing a person administering Atrovent HFA inhaler by holding it near their mouth and pressing the canister to release the medication, demonstrating proper inhaler use technique.*

FDA Label Image

Atrovent 06

An instructional illustration depicting the proper use of an inhaler device. The image shows a person holding the inhaler with the mouthpiece positioned near the mouth, demonstrating the recommended inhalation technique likely associated with Atrovent HFA inhalation aerosol usage by RPK Pharmaceuticals, Inc.*

FDA Label Image

Atrovent 07

An instructional diagram depicting the use of the Atrovent HFA inhaler, showing steps for proper inhalation technique with the device.*

FDA Label Image

Atrovent 08

An instructional illustration showing a person shaking and removing the cap from an Atrovent HFA inhaler before use. The image demonstrates the initial steps for preparing the inhaler for administration.*

FDA Label Image

Atrovent 09

Atrovent HFA inhaler canister showing a dose counter with visible numbers 60, 40, and 20. The labeler is RPK Pharmaceuticals, Inc., and the product NDC is 53002-8410. The image focuses on the inhaler's dose indicator window.*

FDA Label Image

Atrovent 10

The image shows the top portion of an Atrovent HFA inhaler canister with a dose counter window. The label indicates the inhaler is from RPK Pharmaceuticals, Inc., and the dose counter displays a number, indicating remaining doses.*

FDA Label Image

Atrovent 10a

FDA Label Image

Label Image (Lbl530028410)

Atrovent HFA inhalation aerosol label for the 12.9 g product by RPK Pharmaceuticals, Inc. The label indicates Rx only status with directions to inhale a specified number of puffs per day. The label includes patient name fields, lot and expiration date spaces, usage warnings, and barcode. The inhaler product NDC is 53002-8410.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.